# Treatment of Asian Flushing Syndrome With Topical Alpha Agonists

> **NCT03497442** · EARLY_PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 20 (actual)

## Conditions studied

- Flushing
- Alcohol-Related Disorders
- Aldehyde Dehydrogenase Deficiency

## Interventions

- **DRUG:** Brimonidine Tartrate
- **DRUG:** Placebo Vehicle Gel

## Key facts

- **NCT ID:** NCT03497442
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-12
- **Primary completion:** 2019-03-25
- **Final completion:** 2019-03-25
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03497442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03497442, "Treatment of Asian Flushing Syndrome With Topical Alpha Agonists". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03497442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*